Active Substance & Generic Molecule Directory
Sodium Valproate in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Sodium Valproate registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
10
Registered Brands
Availability in Malaysia:10 Prescription (MAL-A)
Showing 10 of 10 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL25046032AZ | AGUETTANT Sodium Valproate 400mg/4ml Solution for Injection or Infusion | 400 mg 4 ml | Prescription (MAL-A) | FIRST PHARMACEUTICAL SDN. BHD. | Compare → |
| MAL10070549AZ | ENCORATE 200 MG ENTERIC-COATED TABLETS | 200.00 mg 0 | Prescription (MAL-A) | RANBAXY (MALAYSIA) SDN. BHD. | Compare → |
| MAL19860953AZ | EPILIM 200 ENTERIC-COATED TABLET | 200mg | Prescription (MAL-A) | SANOFI-AVENTIS (MALAYSIA) SDN. BHD. | Compare → |
| MAL19910049AZ | EPILIM CHRONO 500MG (OBLONG FILM C* ) | 145MG | Prescription (MAL-A) | SANOFI-AVENTIS (MALAYSIA) SDN. BHD. | Compare → |
| MAL19950587AZ | EPILIM INTRAVENOUS 400MG/VIAL | 400MG | Prescription (MAL-A) | SANOFI-AVENTIS (MALAYSIA) SDN. BHD. | Compare → |
| MAL19992701AZ | EPILIM SYRUP 200MG/5ML | 200MG/5ML | Prescription (MAL-A) | SANOFI-AVENTIS (MALAYSIA) SDN. BHD. | Compare → |
| MAL20076036AZ | hovid-Valproate Liquid 200 mg/5 ml | 200mg/5ml | Prescription (MAL-A) | HOVID BERHAD | Compare → |
| MAL08031348AZ | Unival Enteric Coated Tablet 200mg | 200 mg | Prescription (MAL-A) | MEDIDATA SDN. BHD. | Compare → |
| MAL07082854AZ | Unival Syrup 200mg/5ml | 200 mg 5 ml | Prescription (MAL-A) | MEDIDATA SDN. BHD. | Compare → |
| MAL05121152AZ | VALPARIN XR 500 TABLET | 145 mg 0 | Prescription (MAL-A) | LABORATORIES TORRENT (MALAYSIA) SDN. BHD. | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.